Loading…
PHARMACOKINETICS OF FLOMOXEF IN CHILDREN UNDERGOING CHRONIC HEMODIALYSIS
The pharmacokinetics of flomoxef (FMOX), an oxacephem antibiotic, were investigated in pediatric patients undergoing chronic hemodialysis. The results are summarized as follows. 1. FMOX was given intravenously in a single dose of 10mg/kg to 5 pediatric patients (ranging from 7 to 15 years of age) un...
Saved in:
Published in: | Japanese journal of antibiotics 1993/07/25, Vol.46(7), pp.511-517 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | Japanese |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The pharmacokinetics of flomoxef (FMOX), an oxacephem antibiotic, were investigated in pediatric patients undergoing chronic hemodialysis. The results are summarized as follows. 1. FMOX was given intravenously in a single dose of 10mg/kg to 5 pediatric patients (ranging from 7 to 15 years of age) undergoing chronic hemodialysis. It was also given in a dose of 5mg/kg to 2 of these patients. Its concentrations in serum and urine were determined using bioassay. Pharmacokinetic analyses were performed using a two compartment open model. 2. The serum concentrations of FMOX, administered in doses of 10mg/kg or 5mg/kg on non-hemodialysis days, were 33.3±4.09μg/ml(mean±standard deviation) and 17.6μg/ml (mean) at 30 minutes after injection, 29.6±3.51μg/ml and 15.9μg/ml at 1 hour, 27.2±2.14μg/ml and 15.1μg/ml at 2 hours, 23.5±1.90μg/ml and 13.0μg/ml at 4 hours, 20.8±2.44μg/ml and 12.2μg/ml at 6 hours, 18.9±1.86μg/ml and 11.0μg/ml at 8 hours, and 9.64±1.43μg/ml and 6.16μg/ml at 24 hours, respectively. 3. The urinary concentrations of FMOX, administered in a dose of 10mg/kg, were 42.4-123μg/ml between 0-6 hours after injection, 14.1-52.5μg/ml between 6-24 hours, and 2.86-23.7μg/ml between 24-48 hours. The urinary excretion rate in the first 48 hours after injection ranged from 9.1 to 10.5%. 4. Pharmacokinetic analyses showed that k10 was 0.070±0.007hr-1, an extremely low value, T 1/2α was 0.51±0.46 hour, moderately prolonged, T1/2/3 was 15.03±1.34 hours, very prolonged, Vc was 0.23±0.03L/kg, a moderately low value, and AUC was 616.5±90.9μg·hr/ml, an extremely high value, in patients undergoing chronic hemodialysis as compared to those values in a child with normal renal function. 5. These findings suggest that FMOX should be administered intravenously once a day at a dose of 10mg/kg to pediatric patients undergoing chronic hemodialysis and that the dose may be lowered to 5mg/kg in some bacterial infections. |
---|---|
ISSN: | 0368-2781 2186-5477 |
DOI: | 10.11553/antibiotics1968b.46.511 |